We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Faults Facebook Page for Thyroid Treatment Tirosint
FDA Faults Facebook Page for Thyroid Treatment Tirosint
The FDA has slapped Institut Biochimique SA (IBSA) and Akirmax Pharmaceuticals with an untitled letter for omitting risk information and important contraindications on a Facebook page promoting the hyperthyroid drug Tirosint.